{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:24:07Z","timestamp":1793467447773,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00203-021-02241-6","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T05:02:35Z","timestamp":1615352555000},"page":"2591-2596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lactococcus-based vaccine against brucellosis: IgG immune response in mice with rOmp16-IL2 fusion protein"],"prefix":"10.1007","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1428-9197","authenticated-orcid":false,"given":"Marzieh","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4043-9216","authenticated-orcid":false,"given":"Mohammad","family":"Rabbani-khorasgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7720-4859","authenticated-orcid":false,"given":"Sayyed Hamid","family":"Zarkesh-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4144-4332","authenticated-orcid":false,"given":"Rahman","family":"Emamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3247-3289","authenticated-orcid":false,"given":"Hamid","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"2241_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF02297320","volume":"19","author":"GG Alton","year":"1987","unstructured":"Alton GG (1987) Control of Brucella melitensis infection in sheep and goats\u2014a review. Trop Anim Health Prod 19:65\u201374","journal-title":"Trop Anim Health Prod"},{"issue":"109","key":"2241_CR2","first-page":"2","volume":"1","author":"MP Capobianco","year":"2016","unstructured":"Capobianco MP, Cassiano GC, da Cruz Furini AA, de Storti Melo LM (2016) Human interleukin 2 (IL-2) promotion of immune regulation and clinical outcomes: a review. J Cytokine Biol 1(109):2\u20134","journal-title":"J Cytokine Biol"},{"key":"2241_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2006.09.008","volume":"757","author":"JD Colmenero","year":"2007","unstructured":"Colmenero JD, Munoz-Roca NL, Bermudez P, Plata A, Villalobos A, Reguera JM (2007) Clinical findings, diagnostic approach, and outcome of Brucella melitensis epididymo orchitis. Diagn Microbiol Infect Dis 757:367\u2013372","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2241_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1574-695X.2006.00145.x","volume":"48","author":"A Contreras-Rodriguez","year":"2006","unstructured":"Contreras-Rodriguez A, Seleem MN, Schurig GG, Sriranganathan N, Boyle SM, Lopez-Merino A (2006) Cloning, expression and characterization of immunogenic aminopeptidase N from Brucella melitensis. FEMS Immunol Med Microbiol 48:252\u2013256","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2241_CR5","doi-asserted-by":"publisher","first-page":"a012476","DOI":"10.1101\/cshperspect.a012476","volume":"3","author":"I Delany","year":"2013","unstructured":"Delany I, Rappuoli R, Seib KL (2013) Vaccines, reverse vaccinology, and bacterial pathogenesis. Cold Spring Harbor Perspect Med 3:a012476","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"2241_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","volume":"46","author":"EMS Dorneles","year":"2015","unstructured":"Dorneles EMS, Sriranganathan N, Andrey PL (2015) Recent advances in Brucella abortus vaccines. Vet Res 46(1):76","journal-title":"Vet Res"},{"key":"2241_CR7","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1016\/j.vaccine.2015.09.013","volume":"33","author":"A Ghasemi","year":"2015","unstructured":"Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH (2015) Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection. Vaccine 33:5532\u20135538","journal-title":"Vaccine"},{"issue":"1","key":"2241_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2859-6-28","volume":"6","author":"J Glenting","year":"2007","unstructured":"Glenting J, Poulsen LK, Kato K, Madsen SM, Fr\u00f8ki\u00e6r H, Wendt C et al (2007) Production of recombinant peanut allergen Ara h 2 using Lactococcuslactis. Microb Cell Fact 6(1):1\u201310","journal-title":"Microb Cell Fact"},{"issue":"7","key":"2241_CR9","doi-asserted-by":"publisher","first-page":"e2760","DOI":"10.1371\/journal.pone.0002760","volume":"3","author":"D Gonzalez","year":"2008","unstructured":"Gonzalez D, Grillo MJ, De Miguel MJ, Ali T, Arce-Gorvel V, Delrue RM, Conde-Alvarez R, Mu\u00f1oz P, L\u00f3pez-Go\u00f1i I, Iriarte M, Mar\u00edn CM, Weintraub A, Widmalm G, Zygmunt M, Letesson JJ, Gorvel JP, Blasco JM, Moriy\u00f3n I (2008) Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS ONE 3(7):e2760","journal-title":"PLoS ONE"},{"key":"2241_CR10","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1016\/j.vaccine.2012.04.036","volume":"30","author":"VK Guptaa","year":"2012","unstructured":"Guptaa VK, Radhakrishnan G, Harms J, Splitter G (2012) Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis. Vaccine 30:4017\u20134022","journal-title":"Vaccine"},{"key":"2241_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00002","author":"Y He","year":"2012","unstructured":"He Y (2012) Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2012.00002","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"2241_CR12","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1128\/IAI.72.7.4031-4039.2004","volume":"72","author":"MJ Izadjoo","year":"2004","unstructured":"Izadjoo MJ, Bhattacharjee AK, Paranavitana CM, Hadfield TL, Hoover DL (2004) Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M. Infect Immun 72(7):4031\u20134039","journal-title":"Infect Immun"},{"key":"2241_CR13","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680\u2013685","journal-title":"Nature"},{"issue":"1","key":"2241_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2859-4-2","volume":"4","author":"Y Le Loir","year":"2005","unstructured":"Le Loir Y, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Berm\u00fadez-Humar\u00e1n LG, Nouaille S, Ribeiro LA, Leclercq S, Gabriel JE, Guimaraes VD, Oliveira MN, Charlier C, Gautier M, Langella P (2005) Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact 4(1):2","journal-title":"Microb Cell Fact"},{"key":"2241_CR15","first-page":"197","volume":"12","author":"JP Liautard","year":"1996","unstructured":"Liautard JP, Gross A, Dornand J, K\u00f6hler S (1996) Interactions between professional phagocytes and Brucella spp. Microbiologia 12:197\u2013206","journal-title":"Microbiologia"},{"key":"2241_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0378-1135(02)00241-9","volume":"90","author":"JE Luna Martinez","year":"2002","unstructured":"Luna Martinez JE, Mejia Teran C (2002) Brucellosis in Mexico: current status and trends. Vet Microbiol 90:19\u201330","journal-title":"Vet Microbiol"},{"key":"2241_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1365-2958.1999.01326.x","volume":"32","author":"SM Madsen","year":"1999","unstructured":"Madsen SM, Arnau J, Vrang A, Givskov M, Israelsen H (1999) Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis. Mol Microbiol 32:75\u201387","journal-title":"Mol Microbiol"},{"issue":"1","key":"2241_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.prevetmed.2004.03.007","volume":"64","author":"A Minas","year":"2004","unstructured":"Minas A, Minas M, Stournara A, Tselepidis S (2004) The effects of Rev-1 vaccination of sheep and goats on human brucellosis in Greece. Prev Vet Med 64(1):41\u201347","journal-title":"Prev Vet Med"},{"key":"2241_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1475-2859-5-14","volume":"5","author":"A Miyoshi","year":"2006","unstructured":"Miyoshi A, Berm\u00fadez-Humar\u00e1n LG, Ribeiro LA, Le Loir Y (2006) Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis. Microb Cell Fact 5:14","journal-title":"Microb Cell Fact"},{"key":"2241_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/10611860410001670035","volume":"11","author":"DS Pontes","year":"2003","unstructured":"Pontes DS, Dorella FA, Ribeiro LA, Miyoshi A, Le Loir Y, Gruss A, Oliveira SC, Langella P, Azevedo V (2003) Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7\/L12 antigen. J Drug Target 11:489\u2013493","journal-title":"J Drug Target"},{"key":"2241_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1871526518666180709121653","volume":"1","author":"M Rezaei","year":"2019","unstructured":"Rezaei M, Rabbani-Khorasgani M, Zarkesh-Esfahani SH, Emamzadeh R, Abtahi H (2019) Prediction of the Omp16 Epitopes for development of an epitope based vaccine against brucellosis. Infect Disord Drug Targets 1:36\u201345","journal-title":"Infect Disord Drug Targets"},{"key":"2241_CR22","first-page":"1","volume":"999","author":"M Rezaei","year":"2020","unstructured":"Rezaei M, Rabbani-Khorasgani M, Zarkesh-Esfahani SH, Emamzadeh R, Abtahi H (2020) Production of Brucella melitensis Omp16 protein fused to the human interleukin 2 in Lactococcus lactis MG1363 toward developing a Lactococcus-based vaccine against brucellosis. Can J Microbiol 999:1\u20137","journal-title":"Can J Microbiol"},{"issue":"2","key":"2241_CR23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1128\/AEM.68.2.910-916.2002","volume":"68","author":"LA Ribeiro","year":"2002","unstructured":"Ribeiro LA, Azevedo V, Le Loir Y, Oliveira SC (2002) Production and targeting of the Brucella abortus antigen L7\/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microbiol 68(2):910\u2013916","journal-title":"Appl Environ Microbiol"},{"key":"2241_CR24","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.vaccine.2011.12.088","volume":"30","author":"D S\u00e1ez","year":"2012","unstructured":"S\u00e1ez D, Fern\u00e1ndez P, Rivera A, Andrews E, O\u00f1ate A (2012) Oral immunization of mice with recombinant Lactococcus lactis expressing Cu, Zn superoxide dismutase of Brucella abortus triggers protective immunity. Vaccine 30:1283\u20131290","journal-title":"Vaccine"},{"issue":"7","key":"2241_CR25","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1128\/IAI.66.7.3183-3189.1998","volume":"66","author":"L Steidler","year":"1998","unstructured":"Steidler L, Robinson K, Chamberlain L, Schofield KM, Remaut E, Le Page RW, Wells JM (1998) Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 66(7):3183\u20133189","journal-title":"Infect Immun"},{"issue":"9","key":"2241_CR26","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1128\/IAI.67.9.4960-4962.1999","volume":"67","author":"A Tibor","year":"1999","unstructured":"Tibor A, Decelle B, Letesson JJ (1999) Outer membrane proteins Omp10, Omp16, and Omp19 of Brucella spp. are lipoproteins. Infect Immun 67(9):4960\u20134962","journal-title":"Infect Immun"},{"issue":"11","key":"2241_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/omi.2015.0105","volume":"19","author":"US Vishnu","year":"2015","unstructured":"Vishnu US, Sankarasubramanian J, Gunasekaran P, Rajendhran J (2015) Novel vaccine candidates against Brucella melitensis identified through reverse vaccinology approach. Omics 19(11):722\u2013729","journal-title":"Omics"},{"key":"2241_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1469-0691.2008.02029.x","volume":"14","author":"JC Wallach","year":"2008","unstructured":"Wallach JC, Ferrero MC, Delpino MV, Fossati CA, Baldi PC (2008) Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina. Clin Microbiol Infect 14:805\u2013807","journal-title":"Clin Microbiol Infect"},{"key":"2241_CR29","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00253-015-6498-0","volume":"99","author":"A Wyszy\u0144ska","year":"2015","unstructured":"Wyszy\u0144ska A, Kobierecka P, Bardowski J, Jagusztyn-Krynicka EK (2015) Lactic acid bacteria\u201420 years exploring their potential as live vectors for mucosal vaccination. Appl Microbiol Biot 99:2967\u20132977","journal-title":"Appl Microbiol Biot"},{"key":"2241_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.molimm.2011.08.009","volume":"49","author":"Y Yang","year":"2011","unstructured":"Yang Y, Wang L, Yin J, Wang X, Cheng S, Lang X, Wang X, Qu H, Sun C, Wang J, Zhang R (2011) Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine. Mol Immunol 49:175\u2013184","journal-title":"Mol Immunol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-021-02241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-021-02241-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-021-02241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T07:24:49Z","timestamp":1623741889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-021-02241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2241"],"URL":"https:\/\/doi.org\/10.1007\/s00203-021-02241-6","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal experiments were approved by the Ethical Research Committee in Arak university of Medical Science (Approval number for immunization of mice: 1396.99).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}